WellRX Acquires Bioreach
November 27, 2024
WellRX, the parent company of ReviveRX and Ways2Well, has acquired Bioreach, a bloodwork and genetics laboratory, to bring advanced diagnostic capabilities in-house. The acquisition is intended to speed testing turnaround, enable deeper diagnostic integration across WellRX’s telehealth, pharmacy and preventative-care offerings, and support scaled delivery of advanced tests to partner clinics and patients nationwide.
- Buyers
- WellRX
- Targets
- Bioreach
- Industry
- Healthcare Services
- Location
- Utah, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.